102 Results for "

PPARδ

" in MedChemExpress (MCE) Product Catalog:
Products (102)

102 Results for "PPARδ" in MCE Product Catalog:

223
223 Publications Verification
Referencia número: HY-16578
No. CAS: 22978-25-2
Target:  

PPAR

Áreas de investigación:  

Cancer

GW9662 is a potent and selective PPARγ antagonist with an IC50 of 3.3 nM, showing 10 and 1000-fold selectivity over PPARα and PPARδ, respectively.
loading...
    loading...
38
38 Cited Publications
Referencia número: HY-16995
No. CAS: 50892-23-4
Synonyms: Wy-14643
Target:  

PPAR

Áreas de investigación:  

Metabolic Disease Inflammation/Immunology

Pirinixic acid (Wy-14643) is a potent agonist of PPARα, with EC50s of 0.63 μM, 32 μM for murine PPARα and PPARγ, and 5.0 μM, 60 μM, 35 μM for human PPARα, PPARγ and PPARδ, respectively.
loading...
    loading...
29
29 Cited Publications
Referencia número: HY-10838
No. CAS: 317318-70-0
Pureza:  99.27%
Synonyms: GW 1516; GSK-516
Target:  

PPAR Autophagy

Áreas de investigación:  

Metabolic Disease Cancer

GW 501516 (GW 1516) is a PPARδ agonist with an EC50 of 1.1 nM .
loading...
    loading...
25
25 Cited Publications
Referencia número: HY-13861
No. CAS: 265129-71-3
Pureza:  99.45%
Target:  

PPAR

Áreas de investigación:  

Cardiovascular Disease

GW7647 is a potent PPARα agonist, with EC50s of 6 nM, 1.1 μM, and 6.2 μM for human PPARα, PPARγ and PPARδ, respectively.
loading...
    loading...
18
18 Cited Publications
Referencia número: HY-13928
No. CAS: 317318-84-6
Pureza:  99.94%
Synonyms: GW610742
Target:  

PPAR

GW0742 is a potent PPARβ and PPARδ agonist, with an IC50 of 1 nM for human PPARδ in binding assay, and EC50s of 1 nM, 1.1 μM and 2 μM for human PPARδ, PPARα, and PPARγ, respectively.
loading...
    loading...
17
17 Cited Publications
Referencia número: HY-15577
No. CAS: 188591-46-0
Pureza:  98.11%
Target:  

PPAR

Áreas de investigación:  

Cancer

GSK3787 is a selective and irreversible peroxisome proliferator-activated receptor δ (PPARδ) antagonist with pIC50 of 6.6.
loading...
    loading...
14
14 Cited Publications
Referencia número: HY-B0637
No. CAS: 41859-67-0
Synonyms: BM15075
Target:  

PPAR

Áreas de investigación:  

Cardiovascular Disease Metabolic Disease

Bezafibrate is an agonist of PPAR, with EC50s of 50 μM, 60 μM, 20 μM for human PPARα, PPARγ and PPARδ, and 90 μM, 55 μM, 110 μM for murine PPARα, PPARγ and PPARδ, respectively; Bezafibrate is used as an hypolipidemic agent.
loading...
    loading...
6
6 Cited Publications
Referencia número: HY-114263
No. CAS: 1454925-59-7
Pureza:  99.07%
Target:  

PPAR

Áreas de investigación:  

Cancer

NXT629 is a potent, selective, and competitive PPAR-α antagonist, with an IC50 of 77 nM for human PPARα, shows high selectivity over other nuclear hormone receptor, such as PPARδ, PPARγ, ERβ, GR and TRβ, IC50s are 6.0, 15, 15.2, 32.5 and >100 μM, respectively . NXT629 has potent anti-tumor activity and inhibits experimental metastasis of cancer cell in animal models .
loading...
    loading...
4
4 Cited Publications
Referencia número: HY-113081
No. CAS: 15763-06-1
Pureza:  99.21%
1-Methyladenosine is an RNA modification that can serve as a tumor marker, with elevated levels in the body associated with cancer development. Following 1-methyladenosine methylation, upregulation of PPARδ expression regulates cholesterol metabolism and activates Hedgehog signaling pathway, driving liver tumorigenesis .
loading...
    loading...
4
4 Cited Publications
Referencia número: HY-112813
No. CAS: 2247372-59-2
Pureza:  99.42%
Áreas de investigación:  

Metabolic Disease

TUG-1375 is an agonist of free fatty acid receptor 2 (FFA2/GPR43), with a pKi of 6.69. TUG-1375 is inactive on FFA3, FFA4, PPARα, PPARγ, PPARδ, LXRα or LXRβ .
loading...
    loading...
3
3 Cited Publications
Referencia número: HY-108568
No. CAS: 87893-55-8
Pureza:  97.50%
Synonyms: 15d-PGJ2; 15-Deoxy-Δ12,14-PGJ2
15-Deoxy-Δ-12,14-prostaglandin J2 (15d-PGJ2) is a cyclopentenone prostaglandin and a metabolite of PGD2. 15-Deoxy-Δ-12,14-prostaglandin J2 is a selective PPARγ (EC50 of 2 µM) and a covalent PPARδ agonist. 15-Deoxy-Δ-12,14-prostaglandin J2 promotes efficient differentiation of C3H10T1/2 fibroblasts to adipocytes with an EC50 of 7 μM .
loading...
    loading...
3
3 Cited Publications
Referencia número: HY-B0760
No. CAS: 42017-89-0
Synonyms: FNF acid
Target:  

PPAR COX

Áreas de investigación:  

Metabolic Disease

Fenofibric acid, an active metabolite of fenofibrate, is a PPAR activitor, with EC50s of 22.4 μM, 1.47 μM, and 1.06 μM for PPARα, PPARγ and PPARδ, respectively; Fenofibric acid also inhibits COX-2 enzyme activity, with an IC50 of 48 nM.
loading...
    loading...
2
2 Cited Publications
Referencia número: HY-20019
No. CAS: 79558-09-1
Target:  

PPAR

Áreas de investigación:  

Metabolic Disease

L-165041 is a cell permeable PPARδ agonist, with Kis of 6 nM and appr 730 nM for PPARδ and PPARγ, respectively, and induces adipocyte differentiation in NIH-PPARδ cells.
loading...
    loading...
2
2 Cited Publications
Referencia número: HY-106278
No. CAS: 343321-96-0
Pureza:  99.44%
Target:  

PPAR

Áreas de investigación:  

Metabolic Disease

GW 590735 is a potent and selective PPARα agonist. GW 590735 showsEC50=4 nM on PPARα and at least 500-fold selectivity versus PPARδ and PPARγ. GW 590735 can be used for the research of dyslipidemia .
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-19522
No. CAS: 851528-79-5
Synonyms: MBX-8025; RWJ-800025
Target:  

PPAR

Áreas de investigación:  

Metabolic Disease

Seladelpar (MBX-8025) is an orally active, potent and specific PPARδ agonist with an EC50 of 2 nM. Seladelpar shows more than 750-fold and 2500-fold selectivity over the PPARα and PPARγ receptors, respectively. Seladelpar can be used for the study of primary biliary cholangitis .
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-106266
No. CAS: 743438-45-1
Pureza:  99.81%
Synonyms: Carfloglitazar
Target:  

PPAR

Áreas de investigación:  

Metabolic Disease

Chiglitazar (Carfloglitazar) is a PPARα/γ dual agonist, with EC50s of 1.2, 0.08, 1.7 μM for PPARα, PPARγ and PPARδ, respectively.
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-19522A
No. CAS: 3026272-26-1
Synonyms: MBX-8025 sodium; RWJ-800025 sodium
Target:  

PPAR

Áreas de investigación:  

Metabolic Disease Inflammation/Immunology

Seladelpar (MBX-8025) sodium salt is an orally active, potent and specific PPARδ agonist with an EC50 of 2 nM. Seladelpar sodium salt shows more than 750-fold and 2500-fold selectivity over the PPARα and PPARγ receptors, respectively. Seladelpar sodium salt hydrochloride can be used for the study of primary biliary cholangitis .
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-19522C
No. CAS: 928821-40-3
Synonyms: MBX-8025 (lysine dihydrate); RWJ-800025 (lysine dihydrate)
Seladelpar Lysine dihydrate (MBX-8025 lysine dihydrate) is an orally active, selective PPAR-δ agonist with an EC50 of 2 nM against hPPAR-δ. Seladelpar Lysine dihydrate reduces serum IL-31 and bile acid levels. It alleviates pruritus symptoms. Seladelpar Lysine dihydrate enhances insulin sensitivity, normalizes levels of hyperglycemia, hyperinsulinemia, glucose disposal capacity, serum lipids and hepatic free cholesterol. It reduces steatosis, hepatic inflammation and improves liver fibrosis. Seladelpar Lysine dihydrate reverses the pathological changes of non-alcoholic steatohepatitis (NASH). It is applicable to research related to primary biliary cholangitis and non-alcoholic steatohepatitis (NASH) .
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-106266B
No. CAS: 2390374-10-2
Synonyms: Carfloglitazar sodium
Target:  

PPAR

Áreas de investigación:  

Metabolic Disease

Chiglitazar (Carfloglitazar) is a PPARα/γ dual agonist, with EC50s of 1.2, 0.08, 1.7 μM for PPARα, PPARγ and PPARδ, respectively.
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-19522B
No. CAS: 928821-41-4
Synonyms: MBX-8025 (lysine); RWJ-800025 (lysine)
Target:  

PPAR

Áreas de investigación:  

Metabolic Disease

Seladelpar (MBX-8025) lysine is an orally active, potent and specific PPARδ agonist with an EC50 of 2 nM. Seladelpar lysine shows more than 750-fold and 2500-fold selectivity over the PPARα and PPARγ receptors, respectively. Seladelpar lysine can be used for the study of primary biliary cholangitis .
loading...
    loading...